{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:48:19Z","timestamp":1761155299739},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can J Anesth\/J Can Anesth"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1007\/bf03022258","type":"journal-article","created":{"date-parts":[[2009,5,3]],"date-time":"2009-05-03T20:24:15Z","timestamp":1241382255000},"page":"S113-S122","source":"Crossref","is-referenced-by-count":16,"title":["Perioperative management of patients receiving vitamin K antagonists","Prise en charge p\u00e9riop\u00e9ratoire des patients trait\u00e9s aux antagonistes de la vitamine K"],"prefix":"10.1007","volume":"53","author":[{"given":"Brigitte E.","family":"Ickx","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annick","family":"Steib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03022258_CR1","doi-asserted-by":"crossref","first-page":"6125","DOI":"10.1016\/S0021-9258(19)41168-X","volume":"250","author":"P Fernlund","year":"1975","unstructured":"Fernlund P, Stenflo J, Roepstorff P, Thomsen J. Vitamin K and the biosynthesis of prothrombin. V. Gammacarboxyglutamic acids, the vitamin K-dependent structures in prothrombin. J Biol Chem 1975; 250: 6125\u201333.","journal-title":"J Biol Chem"},{"issue":"5","key":"BF03022258_CR2","doi-asserted-by":"crossref","first-page":"445S","DOI":"10.1378\/chest.114.5_Supplement.445S","volume":"114","author":"J Hirsh","year":"1998","unstructured":"Hirsh J, Dalen JE, Anderson DR, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 1998; 114(5 suppl): 445S-69S.","journal-title":"Chest"},{"key":"BF03022258_CR3","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/eurheartj\/16.suppl_B.110","volume":"16","author":"C Gohlke-Barwolf","year":"1995","unstructured":"Gohlke-Barwolf C, Acar J, Oakley C, et al. Guidelines for prevention of thromboembolic events in valvular heart disease. Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 1995; 16: 1320\u201330.","journal-title":"Eur Heart J"},{"key":"BF03022258_CR4","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1161\/01.CIR.98.18.1949","volume":"98","author":"RO Bonow","year":"1998","unstructured":"Bonow RO, Carabello B, de Leon AC, et al. Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation 1998; 98: 1949\u201384.","journal-title":"Circulation"},{"issue":"3","key":"BF03022258_CR5","doi-asserted-by":"crossref","first-page":"457S","DOI":"10.1378\/chest.126.3_suppl.457S","volume":"126","author":"DN Salem","year":"2004","unstructured":"Salem DN, Stein PD, Al-Ahmad A, et al. Antithrombotic therapy in valvular heart diseasenative and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126(3 Suppl): 457S-82S.","journal-title":"Chest"},{"key":"BF03022258_CR6","first-page":"1289","volume":"90","author":"Soci\u00e9t\u00e9 Fran\u00e7aise de Cardiologie","year":"1997","unstructured":"Soci\u00e9t\u00e9 Fran\u00e7aise de Cardiologie. Recommandations de la Soci\u00e9t\u00e9 Fran\u00e7aise de Cardiologie concernant les indications et la surveillance du traitement anticoagulant oral. Arch Mal Coeur Vaisseaux 1997; 90: 1289\u20131305.","journal-title":"Arch Mal Coeur Vaisseaux"},{"key":"BF03022258_CR7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199702063360601","volume":"336","author":"S Schulman","year":"1997","unstructured":"Schulman S, Granqvist S, Holmstr\u00f6m M, et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group. N Engl J Med 1997; 336: 393\u20138.","journal-title":"N Engl J Med"},{"key":"BF03022258_CR8","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1056\/NEJM199506223322510","volume":"332","author":"J Hirsh","year":"1995","unstructured":"Hirsh J. The optimal duration of anticoagulant therapy for venous thrombosis. N Engl J Med 1995; 332: 1710\u20131.","journal-title":"N Engl J Med"},{"key":"BF03022258_CR9","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/0002-9149(90)90535-9","volume":"66","author":"AG Turpie","year":"1990","unstructured":"Turpie AG. Anticoagulant therapy after acute myocardial infarction. Am J Cardiol 1990; 66: 1464\u20138.","journal-title":"Am J Cardiol"},{"key":"BF03022258_CR10","doi-asserted-by":"crossref","first-page":"745","DOI":"10.7326\/0003-4819-141-10-200411160-00005","volume":"141","author":"MC Fang","year":"2004","unstructured":"Fang MC, Chang Y, Hylek EM, et al. Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med 2004; 141: 745\u201352","journal-title":"Ann Intern Med"},{"issue":"3","key":"BF03022258_CR11","doi-asserted-by":"crossref","first-page":"627S","DOI":"10.1378\/chest.126.3_suppl.627S","volume":"126","author":"SM Bates","year":"2004","unstructured":"Bates SM, Green IA, Hirsh J, Ginsberg JS. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126(3 Suppl): 627S-44S.","journal-title":"Chest"},{"issue":"3","key":"BF03022258_CR12","doi-asserted-by":"crossref","first-page":"204S","DOI":"10.1378\/chest.126.3_suppl.204S","volume":"126","author":"J Ansell","year":"2004","unstructured":"Ansell J, Hirsh J, Polller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126(3 Suppl): 204S-33S.","journal-title":"Chest"},{"key":"BF03022258_CR13","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1161\/01.CIR.0000142859.77578.C9","volume":"110","author":"MJ Kovacs","year":"2004","unstructured":"Kovacs MJ, Kearon C, Rodger M, et al. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin. Circulation 2004; 110: 1658\u201363.","journal-title":"Circulation"},{"key":"BF03022258_CR14","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1046\/j.1365-2141.2003.04652.x","volume":"123","author":"M Torn","year":"2003","unstructured":"Torn M, Rosendaal FR. Oral anticoagulation in surgical procedures: risks and recommendations. Br J Haematol 2003; 123: 676\u201382.","journal-title":"Br J Haematol"},{"key":"BF03022258_CR15","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/archinte.163.8.901","volume":"163","author":"AS Dunn","year":"2003","unstructured":"Dunn AS, Turpie AG. Perioperative management of patients receiving oral anticoagulation: a systematic review. Arch Intern Med 2003; 163: 901\u20138.","journal-title":"Arch Intern Med"},{"key":"BF03022258_CR16","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199705223362107","volume":"336","author":"C Kearon","year":"1997","unstructured":"Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med 1997; 336: 1506\u201311.","journal-title":"N Engl J Med"},{"key":"BF03022258_CR17","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1177\/000313489906500319","volume":"65","author":"RL Hewitt","year":"1999","unstructured":"Hewitt RL, Chun KL, Flint LM. Current clinical concepts in perioperative anticoagulation. Am Surg 1999; 65: 270\u20133.","journal-title":"Am Surg"},{"key":"BF03022258_CR18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.7326\/0003-4819-122-1-199501010-00006","volume":"122","author":"RH White","year":"1995","unstructured":"White RH, McKittrick T, Hutchinson R, Twitchell J. Temporary discontinuation of warfarin therapy: changes in the international normalized ratio. Ann Intern Med 1995; 122: 40\u20132.","journal-title":"Ann Intern Med"},{"key":"BF03022258_CR19","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0025-6196(11)64893-3","volume":"73","author":"DJ Tiede","year":"1998","unstructured":"Tiede DJ, Nishimura RA, Gastineau DA, Mullany ChJ, Orszulak TA, Schaff HV. Modern management of prosthetic valve anticoagulation. Mayo Clin Proc 1998; 73: 665\u201380.","journal-title":"Mayo Clin Proc"},{"key":"BF03022258_CR20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00001503-199706000-00016","volume":"10","author":"A Bullingham","year":"1997","unstructured":"Bullingham A, Priestley M. Anaesthetic management of patients being treated with anticoagulants. Curr Opin Anaesthesiol 1997; 10: 223\u201339.","journal-title":"Curr Opin Anaesthesiol"},{"key":"BF03022258_CR21","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.14219\/jada.archive.2003.0080","volume":"134","author":"AH Jeske","year":"2003","unstructured":"Jeske AH, Suchko GD;ADA Council on Scientific Affairs and Division of Science; Journal of the American Dental Association. Lack of scientific basis for routine discontinuation of oral anticoagulation therapy before dental treatment. J Am Dent Assoc 2003; 134: 1492\u20137.","journal-title":"J Am Dent Assoc"},{"key":"BF03022258_CR22","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1001\/archinte.163.20.2532-a","volume":"163","author":"KM Chow","year":"2003","unstructured":"Chow KM, Szeto CC. Oral anticoagulant and dental procedures (Letter). Arch Intern Med 2003; 163: 2532.","journal-title":"Arch Intern Med"},{"key":"BF03022258_CR23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1365-2257.2003.00499.x","volume":"25","author":"M Marietta","year":"2003","unstructured":"Marietta M, Bertesi M, Simoni L, et al. A simple and safe nomogram for the management of oral antico agulation prior to minor surgery. Clin Lab Haematol 2003; 25: 127\u201330.","journal-title":"Clin Lab Haematol"},{"key":"BF03022258_CR24","first-page":"172","volume":"28","author":"TT Horlocker","year":"2003","unstructured":"Horlocker TT, Wedel DJ, Benzon H, et al. Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med 2003; 28: 172\u201397.","journal-title":"Reg Anesth Pain Med"},{"key":"BF03022258_CR25","doi-asserted-by":"crossref","first-page":"251","DOI":"10.7326\/0003-4819-137-4-200208200-00009","volume":"137","author":"MA Crowther","year":"2002","unstructured":"Crowther MA, Douketis JD, Schnurr T, et al. Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial. Ann Intern Med 2002; 137: 251\u20134.","journal-title":"Ann Intern Med"},{"key":"BF03022258_CR26","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0002-9149(98)00842-X","volume":"83","author":"R Nee","year":"1999","unstructured":"Nee R, Doppenschmidt D, Donovan DJ, Andrews TC. Intravenous versus subcutaneous vitamin K1 in reversing excessive oral anticoagulation. Am J Cardiol 1999; 83: 286\u20138.","journal-title":"Am J Cardiol"},{"key":"BF03022258_CR27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0736-4679(02)00720-5","volume":"24","author":"C Wjasow","year":"2003","unstructured":"Wjasow C, McNamara R. Anaphylaxis after low dose intravenous vitamin K. J Emerg Med 2003; 24: 169\u201372.","journal-title":"J Emerg Med"},{"key":"BF03022258_CR28","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1001\/archinte.163.20.2469","volume":"163","author":"A Lubetsky","year":"2003","unstructured":"Lubetsky A, Yonath H, Olchovsky D, Loebstein R, Halkin H, Ezrda D. Comparison of oral vs intravenous phy-tonadione (vitamine K1) in patients with excessive anticoagulation: a prospective randomized controlled study. Arch Intern Med 2003; 163: 2469\u201373.","journal-title":"Arch Intern Med"},{"key":"BF03022258_CR29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0049-3848(02)00387-0","volume":"108","author":"JD Douketis","year":"2002","unstructured":"Douketis JD. Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians. Thromb Res 2002; 108: 3\u201313.","journal-title":"Thromb Res"},{"key":"BF03022258_CR30","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1161\/01.CIR.101.10.1083","volume":"101","author":"G Montalescot","year":"2000","unstructured":"Montalescot G, Polle V, Collet JP, et al. Low molecular weight heparin after mechanical heart valve replacement. Circulation 2000; 101: 1083\u20136.","journal-title":"Circulation"},{"key":"BF03022258_CR31","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.amjcard.2003.10.060","volume":"93","author":"SL Amorosi","year":"2004","unstructured":"Amorosi SL, Tsilimingras K, Thompson D, Fanikos J, Weinstein MC, Goldhaber SZ. Cost analysis of \u201cbridging therapy\u201d with low-molecular-weight heparin versus unfractionated heparin during temporary interruption of chronic anticoagulation. Am J Cardiol 2004; 93: 509\u201311.","journal-title":"Am J Cardiol"},{"key":"BF03022258_CR32","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1592\/phco.24.6.649.34740","volume":"24","author":"AC Spyropoulos","year":"2004","unstructured":"Spyropoulos AC, Jenkins P, Bornikova L. A disease management protocol for outpatient perioperative bridge therapy with enoxaparin in patients requiring temporary interruption of long-term oral anticoagulation. Pharmacotherapy 2004; 24: 649\u201358.","journal-title":"Pharmacotherapy"},{"key":"BF03022258_CR33","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1345\/aph.10305","volume":"35","author":"AH Tinmouth","year":"2001","unstructured":"Tinmouth AH, Morrow BH, Cruickshank MK, Moore PM, Kovacs MJ. Dalteparin as periprocedure anticoagulation for patients on warfarin and at high risk of thrombosis. Ann Pharmacother 2001; 35: 669\u201374.","journal-title":"Ann Pharmacother"},{"key":"BF03022258_CR34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11239-005-3120-9","volume":"20","author":"AK Jaffer","year":"2005","unstructured":"Jaffer AK, Ahmed M, Brotman DJ, et al. Low-molecu-lar-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol. J Thromb Thrombolysis 2005; 20: 11\u20136.","journal-title":"J Thromb Thrombolysis"},{"key":"BF03022258_CR35","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0002-9149(99)00341-0","volume":"84","author":"JM Spandorfer","year":"1999","unstructured":"Spandorfer JM, Lynch S, Weitz HH, et al. Use of enoxaparin for the chronically anticoagulated patient before and after procedures. Am J Cardiol 1999; 84: 478\u201380.","journal-title":"Am J Cardiol"},{"key":"BF03022258_CR36","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/heart.89.5.527","volume":"89","author":"I Ferreira","year":"2003","unstructured":"Ferreira I, Dos L, Tornos P, Nicolau I, Permanyer-Miralda G, Soler-Soler J. Experience with enoxaparin in patients with mechanical heart valves who must withhold acenocoumarol. Heart 2003; 89: 527\u201330.","journal-title":"Heart"},{"key":"BF03022258_CR37","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/archinte.164.12.1319","volume":"164","author":"JD Douketis","year":"2004","unstructured":"Douketis JD, Johnson JA, Turpie AG. Low-molecular-weight-heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Arch Intern Med 2004; 164: 1319\u201326.","journal-title":"Arch Intern Med"},{"key":"BF03022258_CR38","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0003-4975(99)00874-7","volume":"69","author":"O Lev-Ran","year":"2000","unstructured":"Lev-Ran O, Kramer A, Gurevitch J, Shapira I, Mohr R. Low-molecular-weight heparin for prosthetic heart valves: treatment failure. Ann Thorac Surg 2000; 69: 264\u20136.","journal-title":"Ann Thorac Surg"},{"key":"BF03022258_CR39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.thromres.2004.10.004","volume":"116","author":"A Bazinet","year":"2005","unstructured":"Bazinet A, Almanric K, Brunet C, et al. Dosage of enoxaparin among obese and renal impairment patients. Thromb Res 2005; 116: 41\u201350.","journal-title":"Thromb Res"},{"key":"BF03022258_CR40","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1538-7933.2004.00648.x","volume":"2","author":"H Bounameaux","year":"2004","unstructured":"Bounameaux H, de Moerloose P. Is laboratory monitoring of low-molecular-weight heparin therapy necessary? No. J Thromb Haemost 2004; 2: 551\u20134.","journal-title":"No. J Thromb Haemost"},{"issue":"4","key":"BF03022258_CR41","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/S0049-3848(99)00085-7","volume":"95","author":"G Pindur","year":"1999","unstructured":"Pindur G, Morsdorf S. The use of prothrombin complex concentrates in the treatment of hemorrhages induced induced by oral anticoagulation. Thromb Res 1999; 95(4 Suppl 1): S57\u201361.","journal-title":"Thromb Res"},{"key":"BF03022258_CR42","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0049-3848(00)00339-X","volume":"100","author":"D Josic","year":"2000","unstructured":"Josic D, Hoffer L, Buchacher A, et al. Manufacturing of a prothrombin complex concentrate aiming at low thrombogenicity. Thromb Res 2000; 100: 433\u201341.","journal-title":"Thromb Res"},{"key":"BF03022258_CR43","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1046\/j.0007-1048.2001.03295.x","volume":"116","author":"FE Preston","year":"2002","unstructured":"Preston FE, Laidlaw ST, Sampson B, Kitchen S. Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients. Br J Haematol 2002; 116: 619\u201324.","journal-title":"Br J Haematol"},{"key":"BF03022258_CR44","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1055\/s-0038-1655992","volume":"77","author":"M Makris","year":"1997","unstructured":"Makris M, Greaves M, Philips WS, Kitchen S, Rosendaal FR, Preston EF. Emergency oral anticoagulation reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb Haemost 1997; 77: 477\u201380.","journal-title":"Thromb Haemost"},{"key":"BF03022258_CR45","doi-asserted-by":"crossref","first-page":"884","DOI":"10.7326\/0003-4819-137-11-200212030-00009","volume":"137","author":"RA Deveras","year":"2002","unstructured":"Deveras RA, Kessler CM. Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate. Ann Intern Med 2002; 137: 884\u20138.","journal-title":"Ann Intern Med"}],"container-title":["Canadian Journal of Anesthesia\/Journal canadien d'anesth\u00e9sie"],"original-title":[],"language":"fr","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03022258.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03022258\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03022258","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:32:25Z","timestamp":1684974745000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03022258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":45,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["BF03022258"],"URL":"https:\/\/doi.org\/10.1007\/bf03022258","relation":{},"ISSN":["0832-610X","1496-8975"],"issn-type":[{"value":"0832-610X","type":"print"},{"value":"1496-8975","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}